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Abstract: Combining diffuse optical tomography methods with Raman
spectroscopy of tissue provides the ability for in vivo measurements of
chemical and molecular characteristics, which have the potential for being
useful in diagnostic imaging. In this study a system for Raman tomography
was developed and tested. A third generation microCT coupled system was
developed to combine 10 detection fibers and 5 excitation fibers with laser
line filtering and a Cytop reference signal. Phantom measurements of
hydroxyapatite concentrations from 50 to 300 mg/ml had a linear response.
Fiber placement and experiment design was optimized using cadaver
animals with live animal measurements acquired to validate the systems
capabilities. Promising results from the initial animal experiments presented
here, pave the way for a study of longitudinal measurements during fracture
healing and the scaling of the Raman tomography system towards human
measurements.
©2015 Optical Society of America
OCIS codes: (110.6955) Tomographic imaging; (170.0110) Imaging systems; (170.5660)
Raman spectroscopy.
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1. Introduction
Raman spectroscopy provides highly specific chemical composition and molecular structure
information on a sample. Raman spectroscopy of biological tissues is widely studied because
the Raman spectrum of tissue is sensitive to compositional alterations caused by aging and
disease. Early uses of Raman spectroscopy and imaging have been conducted on excised
tissue samples in order to obtain high-quality spectra [1]. As an optical spectroscopy method,
Raman spectroscopy is amenable to fiber optic instrumentation, which enables non-invasive
in vivo Raman measurements. Spatially-offset Raman spectroscopy (SORS), involving
collection of back-scattered Raman photons laterally offset from the excitation source, was
first demonstrated in 2005 as a technique for probing subsurfaces [2]. Transmission Raman,
involving collection of Raman photons through a sample, was later developed for noninvasive forensic and pharmaceutical analyses [3, 4]. Since those first reports in SORS and
transmission Raman, we have seen advances in fiber optic probe design, Raman-scattered
photon transport theory, data preprocessing and tissue phantom models [5–10]. There is
potential of transcutaneous Raman spectroscopy, either in a SORS or transmission approach,
for clinical applications in bone disease and breast cancer [11–15].
Our research in animal models and human patients has shown potential of non-invasive
Raman spectroscopy to monitor alterations in bone composition associated with disease or
fracture healing [13, 16]. There are two embodiments in our translational research. The first
embodiment is using SORS to obtain Raman spectra in a defined anatomic location such as
the proximal tibia, wound bed or articular surface [6, 13, 17]. Another approach is detection
of diffusely propagated photons in a 360◦ plane around the excitation source, otherwise
known as Raman tomography. Since our first reports in 2008 [18, 19], a research focus in our
laboratories has been development of Raman tomography for in vivo Raman imaging of bone
in humans or animal models. Since 2010, both in a rat model and human cadaveric
specimens, we have reported measurement of diffusely propagated photons collected from
multiple collection angles [16, 20, 21]. Extension of these principles toward subsurface
measurements in polymers was later reported in 2014 [22].
We adapted principles and analysis tools from diffuse optical tomography for Raman
tomography. A robust method for diffuse optical tomography, including Raman, is to utilize
multiple combined source-detector measurements through tissue with model based
reconstruction of the parameter distribution. Optical tomography methods use transmission
measurements of emitted signals to determine a map of the interior optical properties of the
imaged object, and this approach can be utilized in combination with co-localized images of
the structures from x-ray or microCT imaging. Image-guided optical tomography requires
modeling of scattering, absorption and transmission interactions and how they affect the
measured signal [23], using photon pathways modeled with the diffusion approximation to
the radiation transport equation. The combination of image-defined structures with Raman
tomography can be integrated using open access software NIRFAST (www.nirfast.org).
NIRFAST is an open-source and publically available software tool for modeling near-infrared
light transport in tissue [23, 24]. The combined data set requires a truly optimized hardware
interface in order to provide a stable and reliable Raman signal estimate.
Previous experiments acquiring transcutaneous Raman spectroscopy of bone consisted of
illumination and detection patterns over large areas and measured predominately backscattered photons [25, 26]. The first Raman tomography measurements were reported in
2008, where Raman measurements were acquired in a rectangular array 180 degrees
separated from the illumination location, showed potential for in vivo tomographic studies
[18, 19]. Two interfaces were designed for Raman tomography in rats, where the Raman
signal was collected from multiple angles around an illumination source. However, these
previous interfaces did not address a major concern in Raman spectroscopic tomography
coupled to microCT (or x-ray), which was to ensure accurate measurement of the source and
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detector fiber placement in a way that does not interfere with the microCT image. Multiple
optical fibers are required to interface with the tissue to allow the acquisition of multiple
illumination and collection patterns. Multiple illumination and collection patterns are needed
to collect high signal to noise data in the plane of collection to enable 3D reconstruction with
high repeatability. These requirements need to be balanced with constraints on length of
acquisition the overall size and cost of the system. The focus in this work is around the
development of instrumentation which would yield reliable and repeatable localized Raman
signals from microCT-imaged bones in vivo.
The iterative process of instrument design and building relies upon the feedback obtained
during experimentation. In the duration of previous in vivo rat measurements, we found
design and ergonomic factors which affected instrument performance. Thus, we completely
redesigned and built the specimen illumination apparatus, patient interface and collection
fibers. In this manuscript, we describe the design, build and performance of a third-generation
Raman tomography instrument for in vivo bone measurements.
2. Materials and methods
2.1 Raman spectrograph
The Raman instrument used in these experiments was a commercially-available component
consisting of a Raman spectrograph operating at λ = 785 nm (RNX1, Kaiser Optical Systems
Inc., Ann Arbor, MI, USA). Raman scattered photons were collected using a spectrograph
equipped with a 100μm slit. A low frequency holographic grating produced dispersed light
over the wavenumber region between 100cm−1 and 1800cm−1. The detector was a 1024 x 256
pixel back-illuminated deep-depletion charge coupled device (Andor Classic, Andor
Technologies, Belfast, United Kingdom) cooled to −75°C. Custom-designed and built optical
fiber probes, described below, were coupled to the spectrograph using standard connectors.
2.2 Specimen illumination design
A custom-designed system was built to incorporate an internal Raman intensity standard and
automated laser switching between illumination fibers. The illumination component, shown in
Fig. 1(a), consists of a polymer fiber coupled, through telescoping optics, to a fiber switch
unit. Laser light from the RXN1 instrument was directly coupled, by FC connector, into a 2
meter polyperfluoro-butenylvinylether (Cytop) optical fiber. (Chromis Fiberoptics, Warren,
NJ, USA) Fig. 1(b) shows a Raman spectrum of the Cytop polymer with filtering and without
filtering. Laser light from the polymer cable was collimated, filtered with an 842 nm short
pass filter (Semrock Inc., Rochester, NY, USA) and injected into the input channel on a 1x6
optical fiber switch (Leoni, Nuremburg, Germany) using telescoping optics. Leoni
manufactured the optical fiber switch, with crosstalk characteristics near the noise floor of
detection and channel-to-channel intensity variation was below 6%. Illumination fibers were
coupled into the switch system with a converging lens. Illumination fibers consisted of a
100µm core, 125μm fiber diameter after cladding, and a total diameter of 1.23mm with the
inclusion of the stainless steel ferrule. In-house software was written in Matlab (2013b, The
MathWorks, Natick, MA, USA) to control the switch. The laser intensity varied between 35
and 75mW at the tip of the illumination fiber, depending on alignment.
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Fig. 1. Panel a shows a diagram of the optical set up for illumination channels with the relative
locations of filters and Leoni optical fiber switch. Briefly, laser light (λ = 785 nm) was
delivered into a fluorocarbon polymer (Cytop) fiber and passed through a short-pass filter into
telescoping optics and coupled into the Leoni switch. A custom Matlab script was written to
automatically illuminate individual excitation optical fibers E1-E5. Panel b shows the Raman
spectrum of Cytop polymer with no short pass filter in the optical train (upper spectrum) and
with an 842 nm short pass filter (bottom spectrum).

2.3 Collection fiber bundle
Figure 2 shows details of the collection fiber bundle. A collection fiber bundle was designed
in-house and custom built with the goals of reducing fiber silicon signal and improving
reproducibility in fiber placement (FiberTech Optica Inc., Kitchener, Ontario, Canada). The
collection bundle had 50 total fibers consisting of 10 collection branches and 5 optical fibers
within each collection branch. Low OH fibers were used to decrease fluorescence and Raman
signal generated within the fibers [27]. Individual 100μm core optical fibers were 125μm after
cladding and coating and had a numerical aperture of 0.22. Five individual fibers were placed
in a bundle and those bundled fibers had a diameter of 0.33mm. The fiber bundle was
encapsulated with a stainless steel ferrule to increase the sturdiness of the fiber tip and for a
total diameter of 1.27mm. Even low OH silicon fibers generate Raman signals and
fluorescence. Minimization of endogenous fiber signal enables higher Raman signal to
background for the Raman bands of interest. Our approach was to use an optical fiber at the
tip of each fiber bundle. A 785nm long pass filter was micro-milled and fit to the tip of the
bundle ferrule, shown in Fig. 2(b). A photograph of the bundle tip is shown in Fig. 2(c) to
show the 5 fibers.

a

b

c

Fig. 2. Panel a is an illustration of the collection fibers, with filtering affixed to the tip of the
fiber generated in SolidWorks. A photograph in panel b was taken of two fibers showing the
reflection of the laser filter at the fiber edge. Panel c is a direct view of an illuminated fiber
bundle showing the placement of the 5 fibers inside the bundle.
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2.4 Probe-to-tissue interface
The probe-to-tissue interface was completely redesigned to accommodate additional fibers,
improve fiber positioning and compatibility with the microCT instrument. The redesign also
addressed requirements to design a holder that was efficient, compact and versatile. Figure 3
shows the CAD schematics of the fiber holder created in Solidworks (Dassault Systemes
Solidworks Corp. Waltham, MA, USA). The holder was built with 3D print technology and
parts were printed on an Objet250 (Stratasys Ltd., Eden Prairie, Minnesota).

Fig. 3. CAD diagram of the redesigned fiber holder generated with smaller angular separation
between fiber guides and a smaller OD. These features enabled 15 fibers, an improvement over
the 12 fibers used in an older model. The fiber holder is easily affixed to a patient bed, and the
materials and dimensions are compatible with microCT instrument.

This approach enabled fabrication of smaller-sized features that were not possible using a
traditional machining approach. Fiber guides were created for 15 fibers, 10 collection fibers
and 5 excitation fibers, which was an improvement over the 12 total fibers in previous
holders. The connecting apparatus which affixed the two pieces of the holder was also
redesigned to allow for greater stability and easier fitting with a split where the top 9 fibers
and holder can quickly be placed or removed, and the connecting apparatus was held in place
by 4 nylon set screws.
2.5 Raman data preprocessing and image formation
Calibration of the instrument was performed by collecting spectra of NIST-traceable white
light and neon emission lamp to calibrate the wavenumber axis and correct for wavelengthdependent variations in CCD efficiency. Raman spectra of Teflon or acetaminophen were
acquired to correct the Raman shift for laser wavelength [28]. White light measurements from
each collection fiber bundle were used to calculate which detector pixels corresponded to the
collection fiber bundle. Correction of tissue autofluorescence signal was performed using a
polynomial subtraction method adapted from a report by Zhao et al [29]. In tissue-simulating
phantoms and rat specimens, Raman bands corresponding to bone hydroxyapatite mineral at
~958 cm−1 and Cytop polymer at ~692 cm−1 were identified. Data points for tomographic
reconstruction were determined by peak maxima values, integrated band area values or ratios
(either intensity or area) of two Raman peaks of interest. Tissue phantom data were analyzed
by calculating the intensity ratio of hydroxyapatite band to Cytop band for each collection
fiber bundle and plotting the intensity ratio against the concentration of the hydroxyapatite
inclusion or inclusion diameter.
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Raman and microCT data were used to generate a tomographic reconstruction.
Tomographic reconstructions required the generation of a volume mesh representing soft
tissue and bone tissue regions with differing optical properties. DICOM images from
microCT scans were segmented into regions for animal experiments. Segmentations were
passed through NIRFAST software for generation of finite element meshes. Placement of
source and detectors on the surface of the mesh, is guided by the presence of the fiber guides
in the DICOM images and the inclusion of the displacement and compression of skin tissue
which occurs during experimentation, which is important to include due to the applied
pressure affecting tissue optical properties [30].
Images of the tomographic reconstructions were generated by iterative solving of the
diffusion approximation in NIRFAST, with the driving mechanism being the minimization of
the difference between the experimental measurements and the modeled data. Images
represented the location and intensity of generated Raman photons, known as Raman yield.
Tomographic reconstructions of the Raman yield were performed with both diffuse and a
priori techniques [23]. A priori, or hard prior reconstruction techniques include region
location within the tissue volume with the mesh node information and forces homogeneous
recovered signals. The final image of the reconstruction algorithm was used to determine the
contrast to background ratio (CBR), corresponding to the recovered hydroxyapatite to Cytop
ratio for the bone region divided by the soft tissue region.
2.6 Validation studies in tissue phantoms
Validation studies were performed in tissue-simulating phantoms. We examined the effect of
varying hydroxyapatite concentration for a defined “bone” tissue volume on normalized
Raman hydroxyapatite signal. Cylindrical tissue phantoms were prepared to model the optical
properties and approximate geometry of rat tibia bone and overlying soft tissue. Phantoms
were made with total 25mm diameter to model the rat soft tissue dimensions at the tibia middiaphysis with an 8.5mm diameter “bone” inclusion at the imaging plane. Gelatin phantoms
were prepared using recipes previously described [7]. Briefly, the outer “soft tissue” phantom
consisted of 10% (w/v) gelatin (Accumedia Manufacturers Inc., Lansing, MI, USA) with 10%
(v/v) Liposyn II (Hospira Inc, Lake Forest, IL, USA). The gelatin solution was poured into a
petri dish and allowed to cool. Once solidified, a 25 mm diameter and 18 mm high cylinder
was cut from the bulk and a small hole was cut from off-center using a pipette tip. This hole
was the site for the inner “bone” inclusion. The inner “bone” phantom was prepared by
adding hydroxyapatite (HAp, SigmaAldrich, St. Louis, MO, USA) to 1 ml of a gelatin + 10%
Liposyn II solution and poured into a 1.0 ml centrifuge tube. The tube was gently stirred to
ensure minimal settling of HAp during solidification. The inner “bone” inclusion was ~8.5
mm diameter. In total, 7 “bone” inclusions were prepared at HAp concentrations of 50, 100,
150, 200, 225, 250 and 300 mg/ml. A control “bone” inclusion, composed of 0 mg/ml HAp +
gelatin + 10% Liposyn II, was also prepared. For reference, the physiologic HAp
concentration in bone is approximately 220 mg/ml [31]. The “bone” inclusions were
examined as followed: once inside the centrifuge tube (Fig. 4(b)) and in duplicate after it had
been removed from the tube (Fig. 4(c)).
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Fig. 4. Photograph (panel a) of an example tissue phantom in the fiber holder. During
experiments, the “bone” inclusion was removed from the centrifuge tube and inserted into the
outer “soft tissue” phantom. The illumination pattern is shown on the interior of the fiber
holder, using E1-E5 to denote excitation fibers and C1-C10 to denote collection fibers. E2 was
the excitation fiber used. Raman data were collected from all 10 collection fibers. Approximate
degrees of separation for C2, C5, C6 and C8 are shown exterior to the fiber holder. Data from
these collection fibers are presented in Figs. 7 and 8. Panel b is a cartoon of the bone inclusion
inside the phantom while inside the polymer centrifuge tube, representing a 2-layer inclusion.
Panel c is a cartoon of the bone inclusion inside the phantom after it has been removed from
the polymer centrifuge tube, representing a single layer inclusion.

Phantoms were stored in an airtight container at 4◦C when not in use and measured within
a week of preparation. For Raman measurements, the phantom was placed into the patient
interface, shown in Fig. 4 and excitation fiber 2 was used to illuminate the phantom. We used
the excitation/collection fiber pattern that was optimized for in vivo use, denoted in Fig. 4.
The optimized fiber pattern was determined using a cadaver animal, where the possible
illumination patterns were tested to ensure sufficient excitation light delivery to the region of
interest while still generating a full tomographic data set. Results were analyzed to determine
greatest Raman signal from the bone and highest level of consistency in producing data above
the noise floor. Additionally, this illumination pattern was chosen as the grouping of
excitation fibers near the bone generates the greatest fluence while having sufficient number
of detection fibers near.
Raman signal was collected for 600 seconds to obtain a good signal-to-noise spectrum
that did not require post-processing smoothing correction. In order to ensure consistent fiber
alignment during this study, the fibers were not moved in between measurements. Only the
“bone” inclusion was removed after the measurement while keeping the outer “soft tissue”
phantom in place. Another “bone” inclusion, at a different HAp concentration was then
inserted into the inclusion site and a Raman spectrum was collected. The “bone” inclusions
were examined in random order.
2.7 Validation studies in cadaveric and live rat specimens
The second series of validation studies was performed in cadaveric (n = 2) and live (n = 1)
rats. The illumination/collection pattern, interface setup time and signal collection parameters
were optimized in cadaveric rat specimens. Parameters were adjusted to have the highest
signal to noise ratio while remaining within the time restraints of animal experimentation. The
live rat was obtained from another study which was approved by the University of Michigan
University Committee on the Care and Use of Animals. Skeletally mature 6 month old male
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Sprague-Dawley rats were sacrificed as part of another study. Frozen cadaveric rats were
brought to room temperature and the right tibia was prepared for examination by the Raman
system and microCT. Fur was removed from the right tibia using either an electric razor or a
depilatory. A thin layer of glycerol was applied to the skin to facilitate fiber coupling to the
tissue. Fibers were placed in the fiber guides until the fiber made close contact with the skin
and the guide was tightened in place with a set screw.
The ability to reproduce measured signals accurately without physically moving of fibers
was tested with a cadaveric rat specimen. Spectra were acquired for 180, 300 and 600 seconds
to determine an optimal measurement time. After polynomial fitting to remove background
signal, the Cytop and hydroxyapatite signals were calculated and the average of signal
intensity for 10 detection fibers when illuminated closest to the bone site was taken as the
data point, shown in Fig. 5.
600
500

Fit to Raman Data
Fit to Cytop Data

400
300
200
100
0
0

100

200

300

400

Acquisition Time (sec)

500

600

Fig. 5. Multiple Raman measurements were collected from the same animal without changing
the location of the optical fibers to determine the linearity of Cytop and Raman signals with
integration time. As expected, Cytop and Raman signals scale linearly with time. This study
suggests that a minimal integration time of 69 seconds, indicated by a black X, in the “Fit to
Raman Data” trend line would provide Raman signal above the noise floor.

The pattern of excitation and collection fibers around the imaging place was also
iteratively moved to optimize collection of transcutaneous bone signal. The optimized pattern,
also used for tissue phantom and live rat measurements, is shown in Fig. 4. The patient
interface in use on a live, anesthetized, rat is shown in Fig. 6a and a cross section view from
the microCT scan in Fig. 6(b) shows moderate tissue indentation at sites where the fiber
guides are in contact with the tissue.
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a

b

Fig. 6. Panel a shows a rat tibia in the fiber holder with fibers placed around the leg. Panel b
shows a microCT image showing the fiber guides on the surface and the deformation caused
by placement on the exterior of the leg. Areas in pink are the tibia and fibula and the area
colored in green represents soft tissue consisting of muscle, tendon and skin.

In another study, repeatability tests were performed by collecting Raman data from a rat
specimen for two consecutive days. Tomographic reconstructions were performed and the
normalized bone Raman parameter for the bone region to the background was determined for
diffuse and hard prior reconstructions.
3. Results
3.1 Assessing Cytop as a reference intensity standard
Earlier studies had described the use of a fluoropolymer fiber as a reference intensity standard
[32]. However, we found significant overlapping Cytop signal in the bone matrix region
(1200-1800 cm−1). Cytop signal could not be removed using software subtraction routines
without affecting the shape of important bone collagen band envelopes. As shown in Fig.
1(b), inclusion of an 842 nm short pass filter into the illumination system removed bands in
the 1200-1800 cm−1 spectral region. As shown in Fig. 5, Cytop signal scaled linearly with
acquisition time. Linear fitting of these data points generated a R2 value of 1 for the Raman
data and 0.9992 for the Cytop data. The location of the x-intercept on the Raman line, marked
with a black X in Fig. 5, indicates the minimum exposure time necessary for a signal above
the noise floor, which is equivalent to 69 seconds. However, experimental times longer than
69 seconds would be required to obtain significant Raman signal. These data suggest that
Cytop polymer fibers are suitable for a reference standard in fiber-optic Raman
measurements.
3.2 Tissue Phantom Validation Studies
Data from tissue phantom and rat specimens demonstrate feasibility of transcutaneous bone
measurements. In general, we found that the third-generation instrument generated high
quality spectroscopic and imaging data, with improved ergonomics and compatibility with
microCT. Initial tissue phantom data shows good linearity of HAp signal and suggests that,
while most of the sampling occurs at the “bone” surface, there is some subsurface sampling.
The sensitivity of the system was determined through phantoms with decreasing contrast to
background values. Tomographic measurements allowed for simultaneous measurement of
the reference Cytop polymer and HAp Raman signals. The baselined intensity value for all
source detector pairs was calculated from the spectrum. Normalized HAp Raman data for
source-detector separations at approximately 45, 90, 135 and 180 degrees were plotted against
HAp concentration, shown in Fig. 7.
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Fig. 7. Raman spectra of tissue phantoms were used to determine noise floor and attenuation
region for the measurement of hydroxyapatite (HAp) with the current system. These
measurements were performed with the bare bone inclusion after it was removed from the
plastic centrifuge tube. Raman HAp signal normalized to Cytop Raman signal is shown against
the concentration of HAp in the “bone” inclusion. Collection signal from collection fibers
corresponding to approximately 45◦, 90◦, 135◦ and 180◦ are presented.

The data show that the normalized HAp Raman signal increased with concentration and
generally followed a linear relationship for all source-detector pairs. The data from this
phantom test supports our hypothesis that the instrumentation provides suitable contrast, at all
degrees of collection, for physiologically-relevant HAp concentrations. These results suggest,
at physiological levels of HAp, most of the Raman photons are being generated at the surface
of the inclusion and little light is propagated through the inclusion.
Even though phantom data indicate minimal photon propagation through the inclusion,
our tests suggest that subsurface sampling of the inclusion does occur. Measurements of the
2-layer bone inclusion, with the bone phantom + the plastic centrifuge tube, shown in Fig.
4(b), demonstrated recovery of both tube material and HAp signal. Figure 8(a) shows
averaged Raman spectra of tissue phantoms with the bone inclusion inside the centrifuge tube
material. As expected, the spectra show contributions from Cytop and the centrifuge tube
material (denoted by a * in the figure). However, we were also able to recover subsurface
hydroxyapatite signal. Figure 8(b) shows the normalized HAp signal as a function of HAp
concentration. The R2 values of trend lines were >0.9 for 45, 90 and 135 degrees, indicating a
linear response. We observed similar trends of increased spread in the data at high HAp
concentrations and less variability in signal recovered from fibers closer to the illumination
source.
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Fig. 8. Raman spectra of tissue phantoms were used to determine noise floor and attenuation
region for the measurement of HAp with the current system. These measurements were
performed with the 2-layer bone inclusion, which was the “bone” phantom inside its plastic
centrifuge tube. Panel a shows Raman HAp signal normalized to Cytop Raman signal is shown
against the concentration of HAp in the “bone” inclusion. The spectra show signatures from
Cytop, centrifuge material (denoted with an *) and HAp. The control inclusion does not have
any signatures from HAp. Panel b shows normalized HAp signal from collection fibers
corresponding to approximately 45◦, 90◦, 135◦ and 180◦. The data shows trends of increased
Raman signal collected at 180◦ and increased spread at higher HAp concentrations.

3.3 Rat specimen validation studies
An in vivo animal protocol was developed for sequential acquisition of Raman and microCT
data sets. Based on the advice of our animal handling experts, we established a maximum
experiment time of 50 minutes. The Raman and microCT measurements together take 40
minutes, leaving only 10 minutes to place the tibia into the holder and set up the fiber system.
A streamlined workflow enabled rapid (7 minutes) Raman probe setup in a cadaveric rat and
we tested this workflow on a live anesthetized rat. The described optimized workflow is also
used in our ongoing in vivo longitudinal study of a rat fracture healing model. We observed
that live rats generally tolerated the Raman/microCT procedure well. There were temporary
indentations on the skin caused by contact of the fiber guides, which persisted less than an
hour after the procedure. The indentations did not penetrate the skin or restrict the animal’s
movement.
Optical measurements were acquired on two consecutive days for the in vivo study and a
comparison of the reconstruction results was done to determine the effect of day-to-day
variations. Reconstructions completed with diffuse parameters led to a mean normalized CBR
value of 2.4 ± 0.3 over the two days. Inclusion of hard priors in the reconstruction led to a
mean CBR value of 9.6 ± 6.3. The contrast to background ratio for each day of measurements
is presented in Table 1.
Table 1. Contrast to background values for diffuse Raman reconstructions from data
acquired on a live rat indicating the day-to-day variation in recovered bone to cytop
signal within the bone region compared to the soft tissue region as defined in the
microCT images used for image segmentation.
Experiment Date
January 29
January 30

Diffuse
2.6
2.2

Hard
14.1
5.2

4. Discussion
The third-generation system makes important improvements to earlier prototypes that enable
quantitative Raman tomography and improved image reconstruction. Importantly,
tomographic reconstructions were completed using a full 360 degrees of data collection rather
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than a SORS-type backscatter measurement on the same surface of the leg [18, 19, 25, 26].
We have demonstrated feasibility of transcutaneous Raman tomography.
The Raman tomography instrumentation used in our previous studies had major
instrumentation limitations that our new design addresses. We discuss four improvements to
the instrument; the removal of metal from the holder, the inclusion of increased locations for
illumination fibers through a fiber switch, an internal reference in Cytop, and laser line
filtering with submillimeter filters at the tip of collection fibers.
A major limitation in previous prototypes was the use of metal rings to hold the specimen
rigid and align the fibers with the surface [21]. However, the metal holder made coupling to
microCT impractical. We have addressed this concern by fabricating the new holder entirely
from polymers which allows for the collection of microCT scans without removing the fiber
holder. The second instrumentation limitation in previous design was the use of a single fiber
as the excitation source. This limitation in probe design required the single fiber to be
manually moved from position to position around the ring which increased fiber placement
errors and prolonged the experiment time. To address this second major issue, the new design
uses 5 excitation fibers and a fiber switch, eliminating the need to manually switch excitation
fiber positions.
We have also included improvements to the laser delivery system. Inclusion of a filtered
Cytop fiber section, for measurement of a reference standard signal, corrects for coupling
variations. This approach is similar to the Born technique used in other diffuse tomography
studies [33]. Integration of a fiber switch into the illumination pathway allows for a reduction
in the fiber coupling error while selectively illuminating one fiber for excitation. To our
knowledge, this is the first report of incorporating of a laser line filter at the tip of the
collection bundles with a submillimeter diameter. While other groups have reported laser line
filtering, the diameter of the filter was limited to commercially available sizes. Our micromilling approach now enables laser line filtering for micrometer diameter probes. The
technological features in the described system can be extended to other fiber-optic Raman
probes.
Phantom measurements enabled us to characterize the instrument response to bone-like
mineral levels. The geometry of a cylindrical tissue phantom approximates the plane in which
the Raman tomography measurements were made on rat tibiae. We showed evidence that
subsurface sampling of a bone inclusion is possible using our instrumentation. This
observation may have important implications for non-invasive measurement of cancellous
bone, where more rapid bone remodeling events occur than in cortical bone. Further tests in
rat bone tissue are underway to confirm these tissue phantom results. Similar tissue phantoms
can be made to model potential clinical conditions including generalized bone mineral loss or
localized bone erosion. Anthromorphic phantoms described by Esmonde-White et al and
Michaelsen et al would enable a multivariate model to simultaneously measure a defined
bone volume and hydroxyapatite levels [7, 34].
Our in vivo animal protocol allowed us to complete our measurements in the
recommended time. We confirmed no permanent damage to the rats. Day-to-day variations in
the contrast to background is most likely affected by subjective variables such as user
experience. These may manifest in placement of the fiber pattern and location with respect to
the bone. We also found the amount of pressure applied to the surface by the fibers and fiber
guides can affect the efficiency in which light couples into the tissue. For hard prior
reconstructions small changes in the amount of signal caused by any of these parameters can
lead to large variations in the reconstructed values.
Non-invasive Raman measurement of bone in an in vivo setting has important
implications for the future musculoskeletal diagnostics. While we report the Raman
tomography instrument using phantoms or rat specimens, the probe-to-tissue interface can be
scaled to accommodate human-sized anatomic sites such as the distal radius and fingers.
Extension to multiplane tomography in the clinic can be achieved through the addition of
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multiple fiber holders and detectors, with the eventual goal of a custom-designed interface for
human use. Our experimental approach and instrumentation was designed with an eventual
goal of in vivo human use. An important consideration is laser safety. Preclinical animal
studies do not define maximum laser exposure limits. Nonetheless, we anticipated
translational studies in humans using comparable technology. As such, our rat measurements
used the American National Standards Institute (ANSI) guideline, Z136.1-2007 of maximum
permissible exposure (MPE) for continuous illumination (t = 10 sec-30000 sec) in humans. In
human tissue, the ANSI guideline for MPE is 0.3W/cm2 in the wavelength range 750-1050
nm and we used a similar MPE for our rat measurements [13]. Even though higher laser
intensities can be used for diagnostic purposes, we believe adoption of this conservative
guideline has facilitated favorable review of our approved human clinical study protocols (n =
2) by the University of Michigan Institutional Review Board.
We foresee two possible areas of clinical applications for the Raman tomography
technology in bone diseases. The first clinical application area is transcutaneous
measurements of bone demineralization at the distal radius which may be indicative of
osteoporosis or other metabolic bone diseases. The second potential clinical application area
is transcutaneous Raman measurements of periarticular bone erosions at the fingers which
may be encountered in rheumatoid arthritis.
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